Skip to content

Effect of blood letting therapy (Siravedha) in treating Hives or Urticaria (Sheetapitta)

Clinical Efficacy of Siravedha Karma in the management of Sheetpitta. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107557
Enrollment
38
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Sponsors

Bharatiya Sanskriti Darshan Trusts Ayurveda Mahavidyala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants between 18 to 60 years of age of either sex with clinical features of Sheetpitta mentioned in Ayurvedic Samhita i.e. Varati-dashta-sansthanavat shotha (wheal resembling insect bite), Toda (pricking pain), Kandu (itching), Chardi (vomiting), Jwara (fever), and Daha (burning sensation), and those suffering from chronic urticaria (symptoms persisting for more than 6 weeks) will be selected for participation in the proposed study.

Exclusion criteria

Exclusion criteria: Participants who are unwilling to provide informed consent or not willing to participate in the study will be excluded. Individuals below 18 years of age or above 60 years will also be excluded. Pregnant and lactating women will not be included in the study. Participants presenting with acute urticaria (symptoms lasting less than 6 weeks) will also be excluded. Individuals with drug-induced urticaria or known allergy to the study medication will not be included. Participants suffering from significant systemic illnesses such as Diabetes Mellitus, Chronic Liver Disease, Cardiac Diseases, or Hypertension will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Siravedha Karma in Sheetpitta.Timepoint: Baseline (Day 0, before initiation of treatment) and after completion of therapy (Day 30).

Secondary

MeasureTime frame
To evaluate the efficacy of Siravedha Karma on hematological parameters of Siravedha Karma that is Absolute Eosinophile CountTimepoint: 0Baseline (Day 0, before initiation of treatment) and after completion of therapy (Day 30).

Countries

India

Contacts

Public ContactVd Prashant Amrutkar

Bhartiya Sanskriti Darshan Trusts Ayurveda Mahavidyalaya

drprashantamrutkar@gmail.com8698282507

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026